travoprost ophthalmic solution

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Glaucoma and ocular hypertension

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Call for patient/clinician input open:

January 31, 2017

Brand Name:

Izba

Project Line:

Reimbursement Review

Project Number:

SR0516-000

Call for patient/clinician input closed:

March 22, 2017

NOC Status at Filing:

Post NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

open-angle glaucoma

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

October 25, 2017

Last Updated : January 31, 2017